ProfileGDS4284 / 207259_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 7% 1% 5% 3% 3% 7% 5% 3% 2% 8% 1% 9% 1% 41% 25% 2% 2% 6% 3% 7% 1% 4% 9% 28% 4% 2% 2% 8% 2% 7% 4% 6% 17% 5% 2% 4% 1% 9% 3% 3% 1% 1% 1% 1% 30% 1% 2% 2% 53% 1% 7% 3% 1% 4% 2% 1% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control11.59067
GSM687648Patient 402 control3.380161
GSM687653Patient 403 control9.706245
GSM687658Patient 404 control7.138453
GSM687663Patient 411 control8.196433
GSM687668Patient 422 control12.43787
GSM687673Patient 424 control10.67145
GSM687678Patient 425 control7.51893
GSM687683Patient 427 control6.937782
GSM687688Patient 428 control12.54838
GSM687695Patient 441 control9.007171
GSM687699Patient 443 control19.24439
GSM687704Patient 444 control3.579651
GSM687707Patient 448 control167.48341
GSM687712Patient 449 control55.955925
GSM687719Patient 450 control6.982812
GSM687724Patient 451 control6.747942
GSM687728Patient 452 control12.59326
GSM687646Patient 401 treated 24h6.58353
GSM687649Patient 402 treated 24h11.0087
GSM687665Patient 411 treated 24h5.357911
GSM687651Patient 402 treated 4 weeks9.047344
GSM687667Patient 411 treated 4 weeks16.88779
GSM687670Patient 422 treated 24h74.122828
GSM687671Patient 422 treated 4 weeks7.766684
GSM687654Patient 403 treated 24h4.650022
GSM687675Patient 424 treated 24h7.274862
GSM687685Patient 427 treated 24h12.88728
GSM687656Patient 403 treated 4 weeks5.155452
GSM687677Patient 424 treated 4 weeks11.56787
GSM687687Patient 427 treated 4 weeks6.675434
GSM687692Patient 428 treated 4h10.73276
GSM687716Patient 449 treated 4h33.574117
GSM687722Patient 450 treated 4h12.62275
GSM687680Patient 425 treated 24h5.360332
GSM687690Patient 428 treated 24h7.937644
GSM687700Patient 443 treated 24h6.419691
GSM687705Patient 444 treated 24h15.25869
GSM687714Patient 449 treated 24h6.628913
GSM687721Patient 450 treated 24h9.395743
GSM687682Patient 425 treated 4 weeks2.113761
GSM687694Patient 428 treated 4 weeks3.52631
GSM687702Patient 443 treated 4 weeks3.099671
GSM687718Patient 449 treated 4 weeks3.276281
GSM687723Patient 450 treated 4 weeks82.920630
GSM687661Patient 404 treated 4h4.801921
GSM687710Patient 448 treated 4h5.410762
GSM687726Patient 451 treated 4h7.734642
GSM687730Patient 452 treated 4h453.26953
GSM687660Patient 404 treated 24h7.414861
GSM687697Patient 441 treated 24h18.80587
GSM687709Patient 448 treated 24h7.975083
GSM687725Patient 451 treated 24h5.314011
GSM687729Patient 452 treated 24h14.58164
GSM687727Patient 451 treated 4 weeks8.200922
GSM687731Patient 452 treated 4 weeks5.159841